Pulmotect announced it raised $10.3 Million in an initial filing
09/09/24, 5:54 PM
Location
Money raised
$10.3 million
Industry
biotechnology
Company Info
Location
3900 essex lane
houston, texas, united states
Additional Info
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.